
140.66 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 105.43 Today|||52-Week Range 183.00 | +9.45% Year-to-Date |
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 139.69 |
Today’s open | 139.69 |
Day’s range | 138.95 - 141.02 |
Volume | 19,549 |
Average volume (3 months) | 951,013 |
Market cap | $24.4B |
Earnings growth (last year) | -205.55% |
Earnings growth (this year) | +4.46% |
Earnings growth (next 5 years) | +23.00% |
Revenue growth (last year) | -27.63% |
P/E ratio | NM |
Price/Sales | 17.88 |
Price/Book | 7.86 |
Today’s change | Today’s % change | |
---|---|---|
HZNPHorizon Therapeutics... | -0.62 | -0.56% |
ALNYAlnylam Pharmaceutic... | -0.11 | -0.05% |
---- | ||
INCYIncyte Corp | -0.37 | -0.43% |
Next reporting date | February 16, 2023 |
EPS forecast (this quarter) | -$1.01 |
Annual revenue (last year) | $1.6B |
Annual profit (last year) | -$674.5M |
Net profit margin | -42.84% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bothell, Washington |